Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 4-Year Analysis of the KEEPsAKE 1 and 2 Trials. J of Skin 2024, 8 (6), s444. https://doi.org/10.25251/skin.8.supp.444.